---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-010731"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:52:10.092218+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CERo Therapeutics prices $5M public offering of shares and warrants at $1.96/unit

## Summary
- Offering of 2,551,020 shares and warrants at combined $1.96 price; gross proceeds ~$5M.
- Warrants exercisable at $1.96 upon shareholder approval, expire 5 years from exercise date.
- Closing expected February 7, 2025; net proceeds for clinical programs and working capital.
- A.G.P./Alliance Global Partners as placement agent; board member and institutional investor participating.
- 90-day lock-up for officers/directors; company restricted from variable rate financings for 180 days.

## SEC filing metadata
- accession: 0001213900-25-010731
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390025010731/0001213900-25-010731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390025010731/ea0230158-8k_cerotherap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-010731
- JSON: https://secwatch.observer/filing/0001213900-25-010731.json
- Plain text: https://secwatch.observer/filing/0001213900-25-010731.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.